CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

TNYATenaya Therapeutics, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $0.60 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$135.35M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-11 · Ali Faraz (Chief Executive Officer) · OTHER
  • 2026-09-11 · Tingley Whittemore (Chief Medical Officer) · OTHER
  • 2026-08-17 · Ali Faraz (Chief Executive Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders113
Shares held68,754,995
Value$60.08M
Percent of shares outstanding30.66%
As of quarter end2026-06-30
RECENT NEWS
  • Tenaya Therapeutics, Inc. (TNYA) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript
  • Tenaya Therapeutics receives FDA RMAT designation for TN-401
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Tenaya Therapeutics, Inc. (TNYA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit